The Phase 1 showed that the dose could be quite large.
The multiple ascending dosage up to a target will show what the effective dosage is. At this point the ideal dosage is unknown no matter what the expectation is.
There is a lot of PK data being taken in the part A that will determine what the appropriate dosage is.